Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life study-Reference-Cited by-同舟云学术

Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life study

Published:2023-07-17 Issue:9 Volume:23 Page:929-936
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Mastorino Luca¹,Burzi Lorenza¹,Frigatti Giada¹,Fazio Alessandra¹,Celoria Valentina¹,Macagno Nicole¹,Rosset Francois¹,Passerini Stefania Ginevra¹,Roccuzzo Gabriele¹,Verrone Anna¹,Stroppiana Elena¹,Ortoncelli Michela¹,Dapavo Paolo¹,Quaglino Pietro¹,Ribero Simone¹

Affiliation:

1. Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2023.2236023

Reference33 articles.

1. Narrative review of the emerging therapeutic role of brodalumab in difficult-to-treat psoriasis;Menter A;Dermatol Ther (Heidelb),2022

2. Localization of treatment‐resistant areas in patients with psoriasis on biologics

3. Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas